Induction and regulation of endogenous granulocyte colony-stimulating factor formation

Biological Chemistry

Volumn 383, Issue 10, 2002, Pages 1501-1517

  Hareng, Lars ^a   Hartung, Thomas ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Cytokine therapy; Haematopoietic growth factors; Infection; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CORTICOSTEROID; CYTOKINE; DICLOFENAC; FLURBIPROFEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GROWTH FACTOR; IBUPROFEN; INDOMETACIN; ISOBUTYLMETHYLXANTHINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOBACTAM DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYLBUTAZONE; PHOSPHODIESTERASE INHIBITOR; PICLAMILAST; PLACEBO; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGICAL ADJUVANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BONE PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DATA ANALYSIS; DIAGNOSTIC TEST; DRUG BLOOD LEVEL; DRUG DEVELOPMENT; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; MOLECULAR BIOLOGY; MYCOSIS; NONHUMAN; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFECTION; INNATE IMMUNITY;

ANIMALIA; BACTERIA (MICROORGANISMS);

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; CLINICAL TRIALS; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY, NATURAL; INFECTION;

EID: 0036803793     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.172     Document Type: Review

References (169)

1. Abraham, E. and Stevens, P. (1992). Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage. Crit. Care. Med. 20, 1127-1133.
2. Allen, R. C., Stevens, P. R., Price, T. H., Chatta, G. S. and Dale, D. C. (1997). In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers. J. Infect. Dis. 175, 1184-1192.
3. Asakawa, H. and Kobayashi, T. (1999). The secretion of cytokines and granulocyte colony stimulating factor by anaplastic and poorly differentiated thyroid carcinoma cell lines. Anti-cancer Res. 19, 761-764.
4. Baba, M., Hasegawa, H., Nakayabu, M., Shimizu, N., Suzuki, S., Kamada, N. and Tani, K. (1995). Establishment and characteristics of a gastric cancer cell line (HuGC- OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF. Am. J. Hematol. 49, 207-215.
5. Bailie, K. E., Irvine, A. E., Bridges, J. M. and McClure, B. G. (1994). Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery. Pediatr. Res. 35, 164-168.
6. Barsig, J., Bundschuh, D. S., Hartung, T., Bauhofer, A., Sauer, A. and Wendel, A. (1996). Control of fecal peritoneal infection in mice by colony-stimulating factors. J. Infect. Dis. 174, 790-799.
7. Basu, S., Hodgson, G., Zhang, H. H., Katz, M., Quilici, C. and Dunn, A. R. (2000). 'Emergency' granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood 95, 3725-3733.
8. Bober, L. A., Grace, M. J., Pugliese-Sivo, C., Rojas-Triana, A., Waters, T., Sullivan, L. M. and Narula, S. K. (1995). The effect of GM-CSF and G-CSF on human neutrophil function. Immunopharmacology 29, 111-119.
9. Boneberg, E. M. and Hartung, T. (2002a). Granulocyte colony-stimulating factor attenuates LPS-stimulated IL-1β, release via suppressed processing of proIL-1β, whereas TNF-α release is inhibited on the level of proTNF-α formation. Eur. J. Immunol. 32, 1717-1725.
10. Boneberg, E. M. and Hartung, T. (2002b). Molecular aspects of anti-inflammatory action of G-CSF Inflamm. Res. 51, 119-128.
11. Boneberg, E. M., Hareng, L., Gantner, F., Wendel, A. and Hartung, T. (2000). Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-γ. Blood 95, 270-276.
12. Brown, C. Y., Lagnado, C. A. and Goodall, G. J. (1996). A cytokine mRNA-destabilizing element that is structurally and functionally distinct from A+U-rich elements. Proc. Natl. Acad. Sci. USA 93, 13721-13725.
13. Burgess, A. W. and Metcalf, D. (1980). The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56, 947-958.
14. Calhoun, D. A., Chegini, N., Polliotti, B. M., Gersting, J. A., Miller, R. K. and Christensen, R. D. (2001). Granulocyte colony-stimulating factor in preterm and term pregnancy, parturition, and intra-amniotic infection. Obstet. Gynecol. 97, 229-234.
15. Calhoun, D. A., Donnellly, W. H., Du, Y., Dame, J. B., Li, Y. and Christensen, R. D. (1999). Distribution of granulocyte colony-stimulating factor (G-CSF) and G-CSF-receptor mRNA and protein in the human fetus. Pediatr. Res. 46, 333-338.
16. Cheers, C., Haigh, A. M., Kelso, A., Metcalf, D., Stanley, E. R. and Young, A. M. (1988). Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect. Immun. 56, 247-251.
17. Coles, L. S., Diamond, P., Occhiodoro, F., Vadas, M. A. and Shannon, M. F. (2000). An ordered array of cold shock domain repressor elements across tumor necrosis factor-responsive elements of the granulocyte-macrophage colony-stimulating factor promoter. J. Biol. Chem. 275, 14482-14493.
18. Dale, D. C., Lau, S., Nash, R., Boone, T. and Osborne, W. (1992). Effect of endotoxin on serum granulocyte and granulocyte-macrophage colony-stimulating factor levels in dogs. J. Infect. Dis. 165, 689-694.
19. Dale, D. C., Liles, W. C., Summer, W. R. and Nelson, S. (1995). Granulocyte colony-stimulating factor-role and relationships in infectious diseases. J. Infect. Dis. 172, 1061-1075.
20. de Wit, H., Dokter, W. H., Esselink, M. T., Halie, M. R. and Vellenga, E. (1993). Interferon-γ enhances the LPS-induced G-CSF gene expression in human adherent monocytes, which is regulated at transcriptional and posttranscriptional levels. Exp. Hematol. 21, 785-790.
21. deBoisblanc, B. P., Mason, C. M., Andresen, J., Logan, E., Bear, M. B., Johnson, S., Shellito, J., Summer, W. R. and Nelson, S. (1997). Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia. Respir. Med. 91, 387-394.
22. Demetri, G. D., Zenzie, B. W., Rheinwald, J. G. and Griffin, J. D. (1989). Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 74, 940-946.
23. Dunn, S., Coles, L., Lang, R., Gerondakis, S., Vadas, M. and Shannon, M. (1994). Requirement for nuclear factor (NF)-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 83, 2469-2479.
24. Dunne, J. R., Dunkin, B. J., Nelson, S. and White, J. C. (1996). Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis. J. Surg. Res. 61, 348-354.
25. Eichacker, P. Q., Waisman, Y., Natanson, C., Farese, A., Hoffman, W. D., Banks, S. M. and MacVittie, T. J. (1994). Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J. Appl. Physiol. 77, 2366-2373.
26. Ernst, T. J., Ritchie, A. R., Demetri, G. D. and Griffin, J. D. (1989). Regulation of granulocyte- and monocyte-colony stimulating factor mRNA levels in human blood monocytes is mediated primarily at a post-transcriptional level. J. Biol. Chem. 264, 5700-5703.
27. Ertel, W., Keel, M., Buergi, U., Hartung, T., Imhof, H. G. and Trentz, O. (1999). Granulocyte colony-stimulating factor inhibits neutrophil apoptosis at the local site after severe head and thoracic injury. J. Trauma 46, 784-792; discussion 792-783.
28. Fattorini, L., Xiao, Y., Li, B., Santoro, C., Ippoliti, F. and Orefici, G. (1994). Induction of IL-1β, IL-6, TNF-α, GM-CSF and G-CSF in human macrophages by smooth transparent and smooth opaque colonial variants of Mycobacterium avium. J. Med. Microbiol. 40, 129-133.
29. Fibbe, W. E., van Damme, J., Billiau, A., Goselink, H. M., Voogt, P. J., van Eeden, G., Ralph, P., Altrock, B. W. and Falkenburg, J. H. (1988). Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood 71, 430-435.
30. Freeman, B. D., Correa, R., Karzai, W., Natanson, C., Patterson, M., Banks, S., Fitz, Y., Danner, R. L., Wilson, L. and Eichacker, P. Q. (1996). Controlled trials of rG-CSF and CD11b-directed mAb during hyperoxia and E. coli pneumonia in rats. J. Appl. Physiol. 80, 2066-2076.
31. Freeman, B. D., Quezado, Z., Zeni, F., Natanson, C., Danner, R. L., Banks, S., Quezado, M., Fitz, Y., Bacher, J. and Eichacker, P. Q. (1997). rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia. J. Appl. Physiol. 83, 1467-1475.
32. Gabrilove, J. L., Welte, K., Lu, L., Castro-Malaspina, H. and Moore, M. A. (1985). Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoletic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor. Blood 66, 407-415.
33. Gaviria, J. M., van Burik, J. A., Dale, D. C., Root, R. K. and Liles, W. C. (1999). Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo. J. Infect. Dis. 179, 1301-1304.
34. Goncalves, A. S. and Appelberg, R. (2001). Effects of recombinant granulocyte-colony stimulating factor administration during Mycobacterium avium infection in mice. Clin. Exp. Immunol. 124, 239-247.
35. Görgen, I., Hartung, T., Leist, M., Niehorster, M., Tiegs, G., Uhlig, S., Weitzel, F. and Wendel, A. (1992). Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α. J. Immunol. 149, 918-924.
36. Gough, A., Clapperton, M., Rolando, N., Foster, A. V., Philpott-Howard, J. and Edmonds, M. E. (1997). Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 350, 855-859.
37. Goya, T., Torisu, M., Doi, F. and Yoshida, T. (1993). Effects of granulocyte colony stimulating factor and monobactam antibiotics (Aztreonam) on neutrophil functions in sepsis. Clin. Immunol. Immunopathol. 69, 278-284.
38. Gross-Weege, W., Dumon, K., Dahmen, A., Schneider, E. M. and Roher, H. D. (1997). Granulocyte colony-stimulating factor (G-CSF) serum levels in surgical intensive care patients. Infection 25, 213-216.
39. Hammond, W. P., Csiba, E., Canin, A., Hockman, H., Souza, L. M., Layton, J. E. and Dale, D. C. (1991). Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J. Clin. Invest. 87, 704-710.
40. Han, J. and Ulevitch, R. J. (1999). Emerging targets for anti-inflammatory therapy. Nature Cell. Biol. 1, E39-40.
41. Han, S. W., Ramesh, N. and Osborne, W. R. (1996). Cloning and expression of the cDNA encoding rat granulocyte colony-stimulating factor. Gene 175, 101-104.
42. Hartung, T. (1998). Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr. Opin. Hematol. 5, 221-225.
43. Hartung, T. (1999). Granulocyte colony-stimulating factor: its potential role in infectious disease. AIDS 13 (Suppl. 2), S3-S9.
44. Hartung, T. and Volk, H.-D., Wendel, A. (1995). G-CSF - an anti-inflammatory cytokine. J. Endo. Res. 2, 195-201.
45. Hartung, T., von Aulock, S. and Wendel, A. (1998). Role of granulocyte colony-stimulating factor in infection and inflammation. Med. Microbiol. Immunol. 187, 61-69.
46. Hartung, T., Doecke, W. D., Bundschuh, D., Foote, M. A., Gantner, F., Hermann, C., Lenz, A., Milwee, S., Rich, B., Simon, B., Volk, H. D., von Aulock, S. and Wendel, A. (1999). Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin. Pharmacol. Ther. 66, 415-424.
47. Hartung, T., von Aulock, S. and Wendel, A. (2000). Growth factors G-CSF and GM-CSF: clinical options. In: Multiple Organ Failure - Pathophysiology, Prevention and Therapy, Vol. Chap. 64, A. E. Baue, E. Faist and D. E. Fry, eds. (New York, Berlin, Heidelberg: Springer), pp. 621-629.
48. Hartung, T., Gaviria, M., Garrido, S. and RK., R. (2001). G-CSF and GM-CSF. In: Cytokine therapeutics in infectious diseases, S. Holland, ed. (Philadelphia, USA: Lippincott Williams & Wilkins), pp. 185-219.
49. Heard, S. O., Fink, M. P., Gamelli, R. L., Solomkin, J. S., Joshi, M., Trask, A. L., Fabian, T. C., Hudson, L. D., Gerold, K. B. and Logan, E. D. (1998). Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. Crit. Care Med. 26, 748-754.
50. Heidari, M. and Kehrli, M. E., Jr. (2000). Cloning, sequencing, and analysis of cDNA encoding bovine granulocyte-colony stimulating factor. Vet. Immunol. Immunopathol. 73, 183-191.
51. Held, T. K., Mielke, M. E., Chedid, M., Unger, M., Trautmann, M., Huhn, D. and Cross, A. S. (1998). Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood 91, 2525-2535.
52. Hill, C. P., Osslund, T. D. and Eisenberg, D. (1993). The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. Proc. Natl. Acad. Sci. USA 90, 5167-5171.
53. Hoang, T., Iscove, N. N. and Odartchenko, N. (1983). Macromolecules stimulating human granulocytic colony-forming cells, precursors of these cells, and primitive erythroid progenitors: some apparent nonidentities. Blood 61, 960-966.
54. Ichinose, Y., Hara, N., Ohta, M., Aso, H., Chikama, H., Kawasaki, M., Kubota, I., Shimizu, T. and Yagawa, K. (1990). Recombinant granulocyte colony-stimulating factor and lipopolysaccharide maintain the phenotype of and superoxide anion generation by neutrophils. Infect. Immun. 58, 1647-1652.
55. Ishii, E., Masuyama, T., Yamaguchi, H., Saito, S., Irie, K., Nomiyama, M., Motoyoshi, K. and Miyazaki, S. (1995). Production and expression of granulocyte- and macrophage-colony- stimulating factors in newborns: their roles in leukocytosis at birth. Acta Haematol. 94, 23-31.
56. Ishikawa, K., Tanaka, H., Matsuoka, T., Shimazu, T., Yoshioka, T. and Sugimoto, H. (1998). Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia. J. Trauma 44, 1047-1054; discussion 1054-1045.
57. Ishizaka, Y., Motoyoshi, K., Hatake, K., Saito, M., Takaku, F. and Miura, Y. (1986). Mode of action of human urinary colony-stimulating factor. Exp. Hematol. 14, 1-8.
58. 2+ ionophore A23187-dependent stabilization of granulocyte-macrophage colony-stimulating factor messenger RNA in murine thymoma EL-4 cells is mediated through two distinct regions in the 3'-untranslated region. J. Immunol. 150, 4386-4394.
59. Karzai, W., von Specht, B. U., Parent, C., Haberstroh, J., Wollersen, K., Natanson, C., Banks, S. M. and Eichacker, P. Q. (1999). G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects. Am. J. Respir. Crit. Care Med. 159, 1377-1382.
60. Katsumata, N., Eguchi, K., Fukuda, M., Yamamoto, N., Ohe, Y., Oshita, F., Tamura, T., Shinkai, T. and Saijo, N. (1996). Serum levels of cytokines in patients with untreated primary lung cancer. Clin. Cancer. Res. 2, 553-559.
61. Kawakami, M., Tsutsumi, H., Kumakawa, T., Abe, H., Hirai, M., Kurosawa, S., Mori, M. and Fukushima, M. (1990). Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76, 1962-1964.
62. Keiser, P., Rademacher, S., Smith, J. W., Skiest, D. and Vadde, V. (1998). Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients. Am. J. Med. 104, 48-55.
63. Kiehntopf, M., Herrmann, F. and Brach, M. A. (1995). Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor α-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts. J. Exp. Med. 181, 793-798.
64. Kikuchi, T., Nakahara, S. and Abe, T. (1996). Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth. J. Neurooncol. 27, 31-38.
65. Koeffler, H. P., Gasson, J., Ranyard, J., Souza, L., Shepard, M. and Munker, R. (1987). Recombinant human TNF α stimulates production of granulocyte colony-stimulating factor. Blood 70, 55-59.
66. Koeffler, H. P., Gasson, J. and Tobler, A. (1988). Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol. Cell. Biol. 8, 3432-3438.
67. Kragsbjerg, P., Holmberg, H. and Vikerfors, T. (1996). Dynamics of blood cytokine concentrations in patients with bacteremic infections. Scand. J. Infect. Dis. 28, 391-398.
68. Kulmburg, P., Radke, M., Mezes, B., Mertelsmann, R. and Rosenthal, F. M. (1997). Cloning and sequence analysis of the immediate promoter region and cDNA of porcine granulocyte colony-stimulating factor. Gene 197, 361-365.
69. Lazard, T., Perronne, C., Cohen, Y., Grosset, J., Vilde, J. L. and Pocidalo, J. J. (1993). Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. Antimicrob. Agents Chemother. 37, 692-695.
70. Le Beau, M. M., Lemons, R. S., Carrino, J. J., Pettenati, M. J., Souza, L. M., Diaz, M. O. and Rowley, J. D. (1987). Chromosomal localization of the human G-CSF gene to 17q11 proximal to the breakpoint of the t(15;17) in acute promyelocytic leukemia. Leukemia 1, 795-799.
71. Lee, S. M., Knoppel, E., van de Ven, C. and Cairo, M. S. (1993). Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3, and macrophage colony-stimulating factor genes in activated cord versus adult mononuclear cells: alteration in cytokine expression may be secondary to posttranscriptional instability. Pediatr. Res. 34, 560-564.
72. Liechty, K. W., Schibler, K. R., Ohls, R. K., Perkins, S. L. and Christensen, R. D. (1993). The failure of newborn mice infected with Escherichia coli to accelerate neutrophil production correlates with their failure to increase transcripts for granulocyte colony-stimulating factor and interleukin 6. Biol. Neonate 64, 331-340.
73. Lieschke, G. J., Grail, D., Hodgson, G., Metcalf, D., Stanley, E., Cheers, C., Fowler, K. J., Basu, S., Zhan, Y. F. and Dunn, A. R. (1994). Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746.
74. Liles, W. C., Waltersdorph, A. M. and Klebanoff, S. J. (1994). Regulation of apoptosis in human neutrophils: effects of proinflammatory mediators. Protein kinase inhibitors and antibodies directed against B2-integrins. Clin. Res. 42, 148a.
75. Liles, W. C., Kiener, P. A., Ledbetter, J. A., Aruffo, A. and Klebanoff, S. J. (1996). Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429-440.
76. Liles, W. C., Huang, J. E., van Burik, J. A., Bowden, R. A. and Dale, D. C. (1997). Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J. Infect. Dis. 175, 1012-1015.
77. Lilly, M. B., Devlin, P. E., Devlin, J. J. and Rado, T. A. (1987). Production of granulocyte colony-stimulating factor by a human melanoma cell line. Exp. Hematol. 15, 966-971.
78. Lindemann, A., Riedel, D., Oster, W., Ziegler-Heitbrock, H. W., Mertelsmann, R. and Herrmann, F. (1989). Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes. J. Clin. Invest. 83, 1308-1312.
79. Lister, P. D., Gentry, M. J. and Preheim, L. C. (1993). Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia. J. Infect. Dis. 168, 922-926.
80. Logan, T. F., Gooding, W., Kirkwood, J. M. and Shadduck, R. K. (1996). Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients. Exp. Hematol. 24, 49-53.
81. Lorenz, W., Reimund, K. P., Weitzel, F., Celik, I., Kurnatowski, M., Schneider, C., Mannheim, W., Heiske, A., Neumann, K., Sitter, H. et al. (1994). Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 116, 925-934.
82. Lu, L., Srour, E. F., Warren, D. J., Walker, D., Graham, C. D., Walker, E. B., Jansen, J. and Broxmeyer, H. E. (1988a). Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-α. Synergism with recombinant human IFN-γ. J. Immunol. 141, 201-207.
83. Lu, L., Walker, D., Graham, C. D., Waheed, A., Shadduck, R. K. and Broxmeyer, H. E. (1988b). Enhancement of release from MHC class II antigen-positive monocytes of hematopoietic colony stimulating factors CSF-1 and G-CSF by recombinant human tumor necrosis factor-alpha: synergism with recombinant human interferon-gamma. Blood 72, 34-41.
84. Lundblad, R., Nesland, J. M. and Giercksky, K. E. (1996). Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit. Care Med. 24, 820-826.
85. Lyman, G. H., Kuderer, N. M. and Djulbegovic, B. (2002). Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis. Am. J. Med. 112, 406-411.
86. Malipero, U. V., Frei, K. and Fontana, A. (1990). Production of hemopoietic colony-stimulating factors by astrocytes. J. Immunol. 144, 3816-3821.
87. -/- mice produce large quantities of interferon-γ in a chronic infection model. Immunology 101, 132-139.
88. Matsushita, K., Arima, N., Yamaguchi, K., Matsumoto, T., Ohtsubo, H., Hidaka, S., Fujiwara, H., Arimura, K., Kukita, T., Tokito, Y., Ozaki, A. and Tei, C. (2000). Granulocyte colony-stimulating factor production by adult T-cell leukaemia cells. Br. J. Haematol. 111, 208-215.
89. McCracken, S. A., Grant, K. E., MacKenzie, I. Z., Redman, C. W. and Mardon, H. J. (1999). Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. Biol. Reprod. 60, 790-796.
90. Mempel, K., Pietsch, T., Menzel, T., Zeidler, C. and Welte, K. (1991). Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 77, 1919-1922.
91. Metcalf, D. (1987). The role of the colony-stimulating factors in resistance to acute infections. Immunol. Cell. Biol. 65, 35-43.
92. Metcalf, D. and Nicola, N. A. (1985). Synthesis by mouse peritoneal cells of G-CSF, the differentiation inducer for myeloid leukemia cells: stimulation by endotoxin, M-CSF and multi-CSF. Leukoc. Res. 9, 35-50.
93. Mroczko, B., Szmitkowski, M. and Czygier, M. (2000). Granulocyte colony stimulating factor (G-CSF) in diagnosis and monitoring of non-small-cell lung cancer (NSCLC). Pol. Arch. Med. Wewn. 103, 163-168.
94. Mueller, M. M. and Fusenig, N. E. (1999). Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int. J. Cancer 83, 780-789.
95. Mueller, M. M., Herold-Mende, C. C., Riede, D., Lange, M., Steiner, H. H. and Fusenig, N. E. (1999). Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am. J. Pathol. 155, 1557-1567.
96. Nagata, S., Tsuchiya, M., Asano, S., Kaziro, Y., Yamazaki, T., Yamamoto, O., Hirata, Y., Kubota, N., Oheda, M., Nomura, H. et al. (1986). Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319, 415-418.
97. Nelson, S. (1994). Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the non-neutropenic host: an overview. Clin. Infect. Dis. 18 (Suppl. 2), S197-204.
98. Nelson, S., Belknap, S. M., Carlson, R. W., Dale, D., DeBoisblanc, B., Farkas, S., Fotheringham, N., Ho, H., Marrie, T., Movahhed, H., Root, R. and Wilson, J. (1998). A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J. Infect. Dis. 178, 1075-1080.
99. Nelson, S., Daifuku, R. and Andresen, J. (1994). Use of Filgrastim (r-metHu-G-CSF) in Infectious Diseases. In: Filgrastim in Clinical Practice, G. Morstyn and G. Dexter, eds. (New York, USA: Marcel Dekker), pp. 253-266.
100. Nelson, S., Summer, W., Bagby, G., Nakamura, C., Stewart, L., Lipscomb, G. and Andresen, J. (1991). Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J. Infect. Dis. 164, 901-906.
101. Nelson, S., Heyder, A. M., Stone, J., Bergeron, M. G., Daugherty, S., Peterson, G., Fotheringham, N., Welch, W., Milwee, S. and Root, R. (2000). A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia. J. Infect. Dis. 182, 970-973.
102. Nicola, N. (1990). Granulocyte colony-stimulating factor. In: Colony-stimulating factors, T. Dexter, J. Garland and N. Testa, eds. (New York, USA: Marcel Dekker), pp. 77-109.
103. Nicola, N. A. and Metcalf, D. (1981). Biochemical properties of differentiation factors for murine myelomonocytic leukemic cells in organ conditioned media - separation from colony-stimulating factors. J. Cell. Physiol. 109, 253-264.
104. Nicola, N. A., Metcalf, D., Matsumoto, M. and Johnson, G. R. (1983). Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J. Biol. Chem. 258, 9017-9023.
105. Nomura, H., Imazeki, I., Oheda, M., Kubota, N., Tamura, M., Ono, M., Ueyama, Y. and Asano, S. (1986). Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J. 5, 871-876.
106. O'Brien, P. M., Seow, H. F., Rothel, J. S. and Wood, P. R. (1994). Cloning and sequencing of an ovine granulocyte colony-stimulating factor cDNA. DNA Seq. 4, 339-342.
107. Oheda, M., Hase, S., Ono, M. and Ikenaka, T. (1988). Structures of the sugar chains of recombinant human granulocyte-colony-stimulating factor produced by Chinese hamster ovary cells. J. Biochem. (Tokyo) 103, 544-546.
108. O'Reilly, M., Silver, G. M., Greenhalgh, D. G., Gamelli, R. L., Davis, J. H. and Hebert, J. C. (1992). Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J. Trauma 33, 679-682.
109. Osslund, T. and Boone, T. (1994). Biochemistry and Structure of Filgrastim (r-metHu-G-CSF). In: Filgrastim in Clinical Practice, G. Morstyn and G. Dexter, eds. (New York, USA: Marcel Dekker), pp. 41-49.
110. Oster, W., Lindemann, A., Mertelsmann, R. and Herrmann, F. (1989). Production of macrophage-, granulocyte-, granulocyte-macrophage- and multi-colony-stimulating factor by peripheral blood cells. Eur. J. Immunol. 19, 543-547.
111. Pajkrt, D., Manten, A., van der Poll, T., Tiel-van Buul, M. M., Jansen, J., Wouter ten Cate, J. and van Deventer, S. J. (1997). Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 90, 1415-1424.
112. Pan, L., Delmonte, J., Jr., Jalonen, C. K. and Ferrara, J. L. (1995). Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86, 4422-4429.
113. Pauksen, K., Elfman, L., Ulfgren, A. K. and Venge, P. (1994). Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br. J. Haematol. 88, 256-260.
114. Peck, K. R., Son, D. W., Song, J. H., Kim, S., Oh, M. D. and Choe, K. W. (2001). Enhanced neutrophil functions by recombinant human granulocyte colony-stimulating factor in diabetic patients with foot infections in vitro. J. Korean Med. Sci. 16, 39-44.
115. Platzer, C., Meisel, C., Vogt, K., Platzer, M. and Volk, H. D. (1995). Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7, 517-523.
116. Platzer, E., Welte, K., Gabrilove, J. L., Lu, L., Harris, P., Mertelsmann, R. and Moore, M. A. (1985). Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J. Exp. Med. 162, 1788-1801.
117. Putland, R. A., Sassinis, T. A., Harvey, J. S., Diamond, P., Coles, L. S., Brown, C. Y. and Goodall, G. J. (2002). RNA destabilization by the granulocyte colony-stimulating factor stem loop destabilizing element involves a single stem-loop that promotes deadenylation. Mol. Cell. Biol. 22, 1664-1673.
118. Quentmeier, H., Zaborski, M. and Drexler, H. G. (1997). The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines. Leukoc. Res. 21, 343-350.
119. Root, R., Nelson, S. and Dale, D. (2000). Filgrastim (r-metHuG-CSF) as adjunctive therapy in the treatment of patients with pneumonia and severe sepsis. Results of a placebo-controlled trial. Am. J. Respir. Crit. Care Med. 161,
120. Roskos, L., Cheung, E., Vincent, M. and Foote, M. (1994). The biology, biochemistry and pharmacology of G-CSF In: Filgrastim in Clinical Practice, G. Morstyn and G. Dexter, eds. (New York, USA: Marcel Dekker), pp. 253-266.
121. Sallerfors, B. and Olofsson, T. (1992). Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) secretion by adherent monocytes measured by quantitative immunoassays. Eur. J. Haematol. 49, 199-207.
122. Schafer, H., Hubel, K., Bohlen, H., Mansmann, G., Hegener, K., Richarz, B., Oberhauser, F., Wassmer, G., Holscher, A. H., Pichlmaier, H., Diehl, V. and Engert, A. (2000). Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy. Ann. Hematol. 79, 143-151.
123. Schmitz, N. and Dreger, P. (1998). Filgrastim (r-metHuG-CSF) in autologous peripheral blood cell transplantation. In: Filgrastim (r-metHuG-CSF) in Clinical Practice, Vol. 19, G. Morstyn, T. M. Dexter and M. Foote, eds. (New York-Basel-Hong Kong: Marcel Dekker, Inc.), pp. 265-280.
124. Seelentag, W., Mermod, J. J. and Vassalli, P. (1989). Interleukin 1 and tumor necrosis factor-α additively increase the levels of granulocyte-macrophage and granulocyte colony-stimulating factor (CSF) mRNA in human fibroblasts. Eur. J. Immunol. 19, 209-212.
125. Seelentag, W. K., Mermod, J. J., Montesano, R. and Vassalli, P. (1987). Additive effects of interleukin 1 and tumour necrosis factor-α on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J. 6, 2261-2265.
126. Seymour, J. F., Lieschke, G. J., Grail, D., Quilici, C., Hodgson, G. and Dunn, A. R. (1997). Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90, 3037-3049.
127. Shannon, M., Pell, L., Lenardo, M., Kuczek, E., Occhiodoro, F., Dunn, S. and Vadas, M. (1990). A novel tumor necrosis factor-responsive transcription factor which recognizes a regulatory element in hemopoietic growth factor genes. Mol. Cell. Biol. 10, 2950-2959.
128. Shannon, M., Coles, L., Fielke, R., Godall, G., Lagnado, C. and Vadas, M. (1992). Three essential promoter elements mediate tumor necrosis factor and interleukin-1 activation of the granulocyte-colony stimulating factor gene. Growth Factors 7, 181-193.
129. Shaw, G. and Kamen, R. (1986). A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
130. Sheridan, J. W. and Metcalf, D. (1972). Studies on the bone marrow colony stimulating factor (CSF): relation of tissue CSF to serum CSF J. Cell. Physiol. 80, 129-140.
131. Shirafuji, N., Asano, S., Matsuda, S., Watari, K., Takaku, F. and Nagata, S. (1989). A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders. Exp. Hematol. 17, 116-119.
132. Simmers, R. N., Webber, L. M., Shannon, M. F., Garson, O. M., Wong, G., Vadas, M. A. and Sutherland, G. R. (1987). Localization of the G-CSF gene on chromosome 17 proximal to the breakpoint in the t(15;17) in acute promyelocytic leukemia. Blood 70, 330-332.
133. Smith, W. S., Sumnicht, G. E., Sharpe, R. W., Samuelson, D. and Millard, F. E. (1995). Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure. Blood 86, 1301-1309.
134. Souza, L. M., Boone, T. C., Gabrilove, J., Lai, P. H., Zsebo, K. M., Murdock, D. C., Chazin, V. R., Bruszewski, J., Lu, H., Chen, K. K. and et, a. l. (1986). Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cell. Science 232, 61-65.
135. Stephens, D. P., Fisher, D. A. and Currie, B. J. (2002). An audit of the use of granulocyte colony-stimulating factor in septic shock. Intern. Med. J. 32, 143-148.
136. Steube, K. G., Meyer, C., Tachibana, M., Murai, M. and Drexler, H. G. (1998). Bladder carcinoma cell line KU-19-19-derived cytokines support proliferation of growth factor-dependent hematopoietic cell lines: modulation by phorbol ester, interferon-γ and interleukin-1 β. Biochem. Biophys. Res. Commun. 242, 497-501.
137. Stoiser, B., Looareesuwan, S., Thalhammer, F., Daxbock, F., Chullawichit,
138. Struzyna, J., Pojda, Z., Braun, B., Chomicka, M., Sobiczewska, E. and Wrembel, J. (1995). Serum cytokine levels (IL-4, IL-6, IL-8, G-CSF, GM-CSF) in burned patients. Burns 21, 437-440.
139. Suga, T., Setoyama, M., Kanekura, T., Hamada, H. and Kanzaki, T. (1998). Morphological, biochemical and molecular biological characteristics of a granulocyte colony-stimulating factor-producing human eccrine carcinoma cell line. J. Dermatol. Sci. 16, 200-207.
140. Taichman, R. S. and Emerson, S. G. (1996). Human osteosarcoma cell lines MG-63 and SaOS-2 produce G-CSF and GM-CSF: identification and partial characterization of cell-associated isoforms. Exp. Hematol. 24, 509-517.
141. Tanaka, H., Ishikawa, K., Nishino, M., Shimazu, T. and Yoshioka, T. (1996). Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J. Trauma 40, 718-725; discussion 725-716.
142. Taveira da Silva, A. M., Kaulbach, H. C., Chuidian, F. S., Lambert, D. R., Suffredini, A. F. and Danner, R. L. (1993). Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N. Engl. J. Med. 328, 1457-1460.
143. Thorpe, R., Wadhwa, M., Bird, C. R. and Mire-Sluis, A. R. (1992). Detection and measurement of cytokines. Blood Rev. 6, 133-148.
144. Toda, H., Murata, A., Matsuura, N., Uda, K., Oka, Y., Tanaka, N. and Mori, T. (1993). Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cells 11, 228-234.
145. Troutt, A. B. and Lee, F. (1989). Tissue distribution of murine hemopoietic growth factor mRNA production. J. Cell. Phys. 138, 38-44.
146. Tsuchiya, M., Asano, S., Kaziro, Y. and Nagata, S. (1986). Isolation and characterization of the cDNA for murine granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. USA 83, 7633-7637.
147. Tsuchiya, M., Kaziro, Y. and Nagata, S. (1987). The chromosomal gene structure for murine granulocyte colony-stimulating factor. Eur. J. Biochem. 165, 7-12.
148. Tsukada, J., Saito, K., Waterman, W. R., Webb, A. C. and Auron, P. E. (1994). Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 β gene. Mol. Cell. Biol. 14, 7285-7297.
149. Tweardy, D. J., Cannizzaro, L. A., Palumbo, A. P., Shane, S., Huebner, K., Vantuinen, P., Ledbetter, D. H., Finan, J. B., Nowell, P. C. and Rovera, G. (1987). Molecular cloning and characterization of a cDNA for human granulocyte colony-stimulating factor (G-CSF) from a glioblastoma multiforme cell line and localization of the G-CSF gene to chromosome band 17q21. Oncogene Res. 1, 209-220.
150. Uemura, Y., Nakata, H., Kobayashi, M., Harada, R., Asahi, Y. and Taguchi, H. (2000). Regulation of granulocyte colony-stimulating factor and parathyroid hormone-related protein production in lung carcinoma cell line OKa-C-1. Jpn. J. Cancer. Res. 91, 911-917.
151. Vandermolen, D. T. and Gu, Y. (1996). Human endometrial expression of granulocyte colony-stimulating factor (G-CSF) and its receptor, stimulation of endometrial G-CSF production by interleukin-1 β, and G-CSF inhibition of choriocarcinoma cell proliferation. Am. J. Reprod. Immunol. 36, 278-284.
152. Vellenga, E., Rambaldi, A., Ernst, T. J., Ostapovicz, D. and Griffin, J. D. (1988). Independent regulation of M-CSF and G-CSF gene expression in human monocytes. Blood 71, 1529-1532.
153. Villa, P., Shaklee, C. L., Meazza, C., Agnello, D., Ghezzi, P. and Senaldi, G. (1998). Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis. J. Infect. Dis. 178, 471-477.
154. von Aulock, S. and Hartung, T. (2002). Potential for immune reconstitution by G-CSF treatment in HIV patients. Arch. Immunol. Ther. Exp. 50, 111-120.
155. von Aulock, S., Boneberg, E. M. and Hartung, T. (2000). Intermittent G-CSF (filgrastim) treatment cannot induce lymphocytosis in volunteers. Clin. Pharmacol. Ther. 68, 104.
156. Watari, K., Asano, S., Shirafuji, N., Kodo, H., Ozawa, K., Takaku, F. and Kamachi, S. (1989). Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73, 117-122.
157. Weiss, M., Gross-Weege, W., Schneider, M., Neidhardt, H., Liebert, S., Mirow, N. and Wernet, P. (1995). Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. J. Crit. Care 10, 21-26.
158. Weiss, M., Fischer, G., Barth, E., Boneberg, E., Schneider, E. M., Georgieff, M. and Hartung, T. (2001). Dissociation of LPS-induced monocytic ex vivo production of granulocyte colony-stimulating factor (G-CSF) and TNF-α in patients with septic shock. Cytokine 13, 51-54.
159. Welte, K., Platzer, E., Lu, L., Gabrilove, J. L., Levi, E., Mertelsmann, R. and Moore, M. A. (1985). Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc. Natl. Acad. Sci. USA 82, 1526-1530.
160. Wenisch, C., Werkgartner, T., Sailer, H., Patruta, S., Krause, R., Daxboeck, F. and Parschalk, B. (2000). Effect of preoperative prophylaxis with filgrastim in cancer neck dissection. Eur. J. Clin. Invest. 30, 460-466.
161. Wesselingh, S. L., Gough, N. M., Finlay-Jones, J. J. and McDonald, P. J. (1990). Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymphokine Res. 9, 177-185.
162. Wieser, M., Bonifer, R., Oster, W., Lindemann, A., Mertelsmann, R. and Herrmann, F. (1989). Interleukin-4 induces secretion of CSF for granulocytes and CSF for macrophages by peripheral blood monocytes. Blood 73, 1105-1108.
163. Wilimas, J. A., Wall, J. E., Fairclough, D. L., Dancy, R., Griffin, C., Karanth, S., Wang, W. and Evans, W. E. (1995). A longitudinal study of granulocyte colony-stimulating factor levels and neutrophil counts in newborn infants. J. Pediatr. Hematol. Oncol. 17, 176-179.
164. Winston, D. J., Foster, P. F, Somberg, K. A., Busuttil, R. W., Levy, M. F., Sheiner, P. A., Reddy, K. R., Fotheringham, N., Armstrong, M. and Logan, E. (1999). Randomized, placebo-controlled, double-blind, multicenter trial of efficacy and safety of granulocyte colony-stimulating factor in liver transplant recipients. Transplantation 68, 1298-1304.
165. Wunderink, R., Leeper Jr, K., Schein, R., Nelson, S., DeBoisblanc, B., Fotheringham, N. and Logan, E. (2001). Filgrastim in patients with pneumonia and severe sepsis or septic shock. Chest 119, 523-529.
166. Yamamoto, A., Iwata, A., Tuchiya, K., Katsumata, A., Oishi, K., Saito, T., Tsujimoto, H., Hasegawa, A. and Ueda, S. (2001). Molecular cloning and expression of the cDNA encoding feline granulocyte colony-stimulating factor. Gene 274, 263-269.
167. Yonem, A., Cakir, B., Guler, S., Azal, O. O. and Corakci, A. (2001). Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes Obes. Metab. 3, 332-337.
168. Zhan, Y., Basu, S., Lieschke, G. J., Grail, D., Dunn, A. R. and Cheers, C. (1999). Functional deficiencies of peritoneal cells from gene-targeted mice lacking G-CSF or GM-CSF J. Leukoc. Biol. 65, 256-264.
169. Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R. and Cheers, C. (1998). Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 91, 863-869.